These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 639047)

  • 1. Arrest of synthesis of specific proteins at the onset of mammary tumor regression.
    Rouleau M; Losonczy I; Gullino PM
    Cancer Res; 1978 Apr; 38(4):926-31. PubMed ID: 639047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased susceptibility of cytosol proteins to proteolytic digestion during regression of a hormone-dependent mammary tumor.
    Rouleau M; Gullino PM
    Cancer Res; 1977 Mar; 37(3):670-7. PubMed ID: 837367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration in gene expression at the onset of hormone-dependent mammary tumor regression.
    Huang FL; Cho-Chung YS
    Cancer Res; 1983 May; 43(5):2138-42. PubMed ID: 6403232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin binding in ovariectomy-responsive and ovariectomy-nonresponsive rat mammary carcinoma.
    Powell BL; Diamond EJ; Koprak S; Hollander VP
    Cancer Res; 1977 May; 37(5):1328-32. PubMed ID: 15719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of cell shedding into efferent blood of mammary adenocarcinoma.
    Butler TP; Gullino PM
    Cancer Res; 1975 Mar; 35(3):512-6. PubMed ID: 1090362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The conversion of an ovariectomy-nonresponsive to an ovariectomy-responsive mammary tumor strain.
    Diamond EJ; Koprak S; Shen SK; Hollander VP
    Cancer Res; 1976 Jan; 36(1):77-80. PubMed ID: 1248010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin and estrogen binding in transplantable hormone-dependent and autonomous rat mammary carcinoma.
    Costlow ME; Buschow RA; Richert NJ; McGuire WL
    Cancer Res; 1975 Apr; 35(4):970-4. PubMed ID: 163700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biological significance of estradiol receptor binding to DNA.
    Khan S; Feldman M; Hollander VP
    Cancer Res; 1980 Apr; 40(4):1050-3. PubMed ID: 7357535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estradiol binding in ovariectomy-responsive and -nonresponsive rat mammary carcinoma.
    Diamond EJ; Giladi M; Khan S; Hollander VP
    Cancer Res; 1977 Jun; 37(6):1852-6. PubMed ID: 870188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of ovariectomy-induced rat mammary tumor regression by a mammosomatotropic tumor.
    Diamond EJ; Khan S; Koprak S; Hollander VP
    Cancer Res; 1978 Aug; 38(8):2239-45. PubMed ID: 208762
    [No Abstract]   [Full Text] [Related]  

  • 11. Alternate fluctuations of leucine and thymidine incorporation by mammary tumors in rats during the estrous cycle.
    Lee C; Murphy JJ; Diamond CA; Rafferty NS; Oyasu R
    Cancer Res; 1977 Sep; 37(9):3301-5. PubMed ID: 406988
    [No Abstract]   [Full Text] [Related]  

  • 12. Origin of the increased activity of beta-glucuronidase in the soluble fraction of rat mammary tumors during ovariectomy-induced regression.
    Beem EP; Hillebrand MJ; Benckhuijsen C; Overdijk B
    Cancer Res; 1987 Aug; 47(15):3980-7. PubMed ID: 3607744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between estrogens, prolactin, and growth hormone on the growth of N-nitrosomethylurea-induced rat mammary tumors.
    Rose DP; Gottardis M
    Anticancer Res; 1985; 5(4):397-402. PubMed ID: 4037735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammary tumor regression. I. Physiopathologic characteristics of hormone-dependent tissue.
    Gullino PM; Grantham FH; Losonczy I; Berghoffer B
    J Natl Cancer Inst; 1972 Nov; 49(5):1333-48. PubMed ID: 4650198
    [No Abstract]   [Full Text] [Related]  

  • 15. Heat-stress proteins and thermal resistance in rat mammary tumor cells.
    Tomasovic SP; Steck PA; Heitzman D
    Radiat Res; 1983 Aug; 95(2):399-413. PubMed ID: 6611857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
    Gandilhon P; Mélançon R; Djiane J; Kelly PA
    J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone, serum, and methylxanthine interactions in the regulation of DNA synthesis in organ-cultured rat mammary tumors.
    Mayer RM; Diamond EJ; Hollander VP
    J Natl Cancer Inst; 1980 Nov; 65(5):1033-8. PubMed ID: 6159497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability in response pattern of DMBA induced mammary tumors of Wistar rats.
    Lahiri T; Lahiri P
    Neoplasma; 1987; 34(5):537-43. PubMed ID: 3122063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.
    Tamarkin L; Cohen M; Roselle D; Reichert C; Lippman M; Chabner B
    Cancer Res; 1981 Nov; 41(11 Pt 1):4432-6. PubMed ID: 6796259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of chromatofocusing to distinguish estradiol receptor from ovarian-dependent and -independent rat mammary tumors.
    Coufalik AH; Feldman M; Platica M; Toth L; Dreiling D; Hollander VP
    Cancer Res; 1983 Nov; 43(11):5235-9. PubMed ID: 6616460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.